Overview
Mumps encephalitis is a rare but serious complication of mumps virus infection, typically occurring in unvaccinated individuals or those with compromised immune systems. Despite the significant decline in mumps incidence following the widespread adoption of the measles, mumps, and rubella (MMR) vaccine, outbreaks continue to highlight the necessity for vigilance in recognizing and managing this condition. Clinical presentations can vary widely, ranging from classic parotitis to severe neurological symptoms without overt salivary gland involvement, particularly in immunocompromised patients. Early diagnosis and isolation are crucial to prevent further transmission and mitigate potential long-term sequelae. This guideline synthesizes key clinical insights from recent case reports to provide clinicians with a comprehensive understanding of mumps encephalitis.
Epidemiology
The incidence of mumps has markedly decreased since the introduction of the MMR vaccine, reflecting its effectiveness in preventing the majority of infections [PMID:17609643]. However, sporadic outbreaks persist, particularly in communities with lower vaccination coverage, underscoring the ongoing risk of mumps-related complications. These outbreaks emphasize the importance of maintaining high vaccination rates to prevent resurgence. Notably, immunocompromised individuals, including those with underlying conditions like Crohn's disease undergoing immunosuppressive therapy, remain at heightened risk for severe mumps infections, including encephalitis [PMID:42031382]. The vulnerability of these populations highlights the need for tailored surveillance and preventive strategies to safeguard against mumps encephalitis.
Clinical Presentation
Mumps encephalitis can present with a spectrum of symptoms that often extend beyond the classic manifestations of parotitis. In immunocompetent individuals, typical symptoms may include fever, parotid gland swelling, pain under the earlobe, headache, and vomiting, often preceding neurological symptoms [PMID:34803019]. However, in more severe cases, particularly among immunocompromised patients, the presentation can be atypical, lacking overt signs of salivary gland involvement. For instance, an adult male with Crohn's disease on immunosuppressive therapy developed acute encephalopathy with seizures and abnormal neuroimaging findings, illustrating how mumps encephalitis can manifest primarily with neurological symptoms [PMID:42031382]. Additionally, a 5-year-old unvaccinated boy experienced profound neurological abnormalities such as akinesia, mutism, dysphagia, and respiratory distress following mumps parotitis, emphasizing the potential for severe neurological complications in pediatric cases [PMID:25809834]. These cases underscore the necessity for clinicians to consider mumps encephalitis in differential diagnoses, especially when neurological symptoms predominate.
Diagnosis
Diagnosing mumps encephalitis can be challenging due to its varied clinical presentations and the subtlety of symptoms in some cases. Early recognition often relies on a high index of suspicion, particularly in unvaccinated or immunocompromised individuals. Neuroimaging plays a pivotal role in confirming the diagnosis when clinical symptoms are ambiguous. For example, brain MRI findings such as hypointense and hyperintense signals in the splenium of the corpus callosum can indicate Mild encephalitis/encephalopathy with a reversible splenial lesion (MERS), a condition associated with mumps [PMID:34803019]. In another case, MRI revealed necrotic changes in critical brain regions like the basal ganglia, midbrain, and hypothalamus, further supporting the diagnosis of mumps encephalitis [PMID:25809834]. These imaging findings are crucial for distinguishing mumps encephalitis from other causes of encephalitis and guiding appropriate management. Delayed diagnosis, as seen in a case where incomplete vaccination history complicated early recognition, highlights the importance of considering mumps in the differential diagnosis even when clinical signs are not typical [PMID:42031382].
Differential Diagnosis
Mumps encephalitis must be differentiated from a wide array of other infectious and non-infectious causes of encephalitis. Common differential diagnoses include other viral encephalitides (e.g., herpes simplex virus, enterovirus), bacterial meningitis, autoimmune encephalitis, and metabolic encephalopathies. The presence of recent mumps infection or exposure, especially in unvaccinated or partially vaccinated individuals, should prompt consideration of mumps encephalitis. In immunosuppressed patients, atypical presentations without parotitis further complicate the differential diagnosis [PMID:42031382]. Additionally, distinguishing mumps-related MERS from other neurological conditions presenting with similar MRI findings is critical. Clinicians should be vigilant in evaluating the patient's vaccination history and recent exposures to guide appropriate diagnostic testing, including serological assays for mumps-specific antibodies and viral detection through PCR [PMID:34803019].
Management
The management of mumps encephalitis primarily focuses on supportive care, given the limited specific antiviral treatments available for mumps. In several reported cases, spontaneous resolution of neurological symptoms and imaging abnormalities occurred without targeted neurological interventions, suggesting that supportive measures such as hydration, seizure control, and respiratory support can be effective [PMID:34803019]. However, in severe cases, such as the 50-year-old man with progressive encephalitis despite treatment with steroid pulse therapy and immunoglobulin, the disease course can be refractory to conventional treatments [PMID:25809834]. This variability underscores the need for individualized care plans, closely monitoring patients for complications and adjusting management strategies as necessary. Early isolation of affected individuals is also crucial to prevent further spread of the virus within communities.
Complications
Mumps encephalitis can lead to significant long-term complications, particularly in severe cases. One notable case reported persistent neurological deficits at one-year follow-up, including bedridden status, dependence on enteral feeding via a gastric fistula, and the need for a tracheostomy, highlighting the potential for debilitating sequelae [PMID:25809834]. These outcomes emphasize the importance of comprehensive follow-up care to address both immediate and long-term health needs of patients recovering from mumps encephalitis. Regular neurological assessments and multidisciplinary support are essential to optimize recovery and manage residual impairments effectively.
Prognosis & Follow-up
The prognosis for mumps encephalitis varies widely depending on the severity of neurological involvement and the patient's overall health status. In milder cases, particularly those diagnosed early and managed supportively, complete recovery with resolution of MRI abnormalities is possible, as evidenced by follow-up imaging showing no abnormalities in the splenium [PMID:34803019]. However, severe cases may result in lasting neurological deficits, underscoring the need for prolonged follow-up to monitor recovery and manage any residual symptoms. Regular clinical evaluations, including neurological assessments and imaging studies, are crucial to track progress and intervene promptly if complications arise.
Special Populations
Certain populations are disproportionately affected by mumps encephalitis due to their immune status. Immunocompromised individuals, such as those with chronic inflammatory conditions like Crohn's disease who are on immunosuppressive therapy, are particularly vulnerable [PMID:42031382]. These patients may present with encephalitis without typical parotitis, making clinical recognition challenging. Pediatric patients, especially those who are unvaccinated, also face heightened risks, as exemplified by cases where neurological symptoms overshadowed the classic signs of mumps [PMID:25809834]. Tailored vaccination strategies and heightened clinical vigilance are essential in these groups to prevent severe outcomes associated with mumps encephalitis.
Key Recommendations
References
1 Munasinghe V, Gopal R, Phyu HE, Elrayes M, Lilleker J, Todd R et al.. Mumps encephalitis in an immunocompromised adult. BMJ case reports 2026. link 2 Lin F, Feng X, Li Z, Fan X, Li J, Xu B et al.. REPORT-Mild encephalitis/encephalopathy with a reversible splenial lesion associated with mumps infection: A case report. Pakistan journal of pharmaceutical sciences 2021. link 3 Suga K, Goji A, Shono M, Matsuura S, Inoue M, Toda E et al.. Mumps encephalitis with akinesia and mutism. Pediatrics international : official journal of the Japan Pediatric Society 2015. link 4 Cooper AD, Wijdicks EF, Sampathkumar P. Mumps encephalitis: return with a vengeance. Reviews in neurological diseases 2007. link